Pacific Edge Set For Medicare Panel Review of Cxbladder Coverage

MT Newswires Live
2025/09/15

Pacific Edge (ASX:PEB, NZE:PEB) received notification from Medicare Administrative Contractor (MAC) Novitas that an expert panel will be convened to review coverage for tests, including Cxbladder Triage, according to a Monday filing with the New Zealand and Australian bourses.

The review will focus on tests referenced in the 2025 update to the American Urological Association (AUA) microhematuria guideline, the filing said.

The contractor advisory committee, made up of urology experts, is set to convene in early 2026 to align Medicare policy with the 2025 AUA guideline update, per the filing.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10